In the present study, we reveal the increased DNA damage accompanied with Chk1 activation in AD human brains and animal and cell models, and demonstrate that neuronal DNA damage-induced Chk1 activation promotes the AD-like pathology by CIP2A upregulation. Here, CIP2A is linked to Alzheimer disease.